MULTI EXPRESS ZERTIFIKAT - DOCMORRIS/CREDIT SUISSE UBS MERGER Stock

Certificat

CH1163994739

Market Closed - Deutsche Boerse AG 11:28:01 2024-05-10 EDT
215.6 EUR +2.01% Intraday chart for MULTI EXPRESS ZERTIFIKAT - DOCMORRIS/CREDIT SUISSE UBS MERGER
Current month+10.86%
1 month+1.11%
Date Price Change Volume
24-05-10 215.6 +2.01% 0
24-05-09 211.3 +0.06% 0
24-05-08 211.2 -2.39% 0
24-05-07 216.4 +8.42% 0
24-05-06 199.6 +1.34% 0

Delayed Quote Deutsche Boerse AG

Last update May 10, 2024 at 11:28 am

More quotes

Static data

Product typesonstige Zertifikate
Buy / SellCALL
Underlying DOCMORRIS AG
Issuer LEONTEQ
WKN A2U0QJ
ISINCH1163994739
Date issued 2022-02-28
Strike 111.2 CHF
Maturity 2025-02-21 (286 Days)
Parity 0.11 : 1
Emission price 1,000
Emission volume N/A
Settlement Beides
Currency EUR

Technical Indicators

Highest since issue 995
Lowest since issue 113.2

Company Profile

Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.
Sector
-
More about the company

Ratings for DocMorris AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: DocMorris AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
74.55 CHF
Average target price
99.24 CHF
Spread / Average Target
+33.12%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW